FP&A Manager

About us:
ZOLL Itamar is an innovative medical device technology company that focuses on the development and manufacturing of Home Sleep Apnea Tests to aid in the diagnosis of respiratory sleep disorders. Our core product is the WatchPAT®️ family, a revolutionary FDA-cleared portable home sleep apnea test device, that is based on propriety signal and analysis. 80% of patients who have sleep apnea are undiagnosed. We are committed to reach those undiagnosed patients and provide testing to promote wellness and enhance overall quality of life. WatchPAT®️ is commercially available within major markets including the U.S., Japan, and Europe, and is the leading home sleep apnea test in the US. ZOLL Itamar’s corporate headquarters, research and development and manufacturing are located in Israel with U.S. headquarters based in Atlanta, GA.

As an FP&A Manager, you will be responsible for overseeing all aspects of financial planning and analysis at Itamar.

Education and Certifications:

BA in Economics/Accounting.

CPA - an advantage.

Duties and responsibilities:

Actively participate in the annual budgeting process.

Profitability & Gross margin analysis.

Utilizing BI tools to deliver meaningful insights into business performance.

Inventory management and control.

Costing.

Management reports.

Budgeting control.

Essential Job Functions:

Strong understanding of accounting principles and financial analysis.

Strong analytical skills.

Strong business application skills (e.g., Microsoft Excel).

Strong communication and influencing skills.

Excellent teamwork skills.

Fluent verbal& wirting English skils.

Any additional terms:
Hybrid work located in Caesarea

ZOLL is a fast-growing company that operates in more than 140 countries around the world. Our employees are inspired by a commitment to make a difference in patients' lives, and our culture values innovation, self-motivation and an entrepreneurial spirit. Join us in our efforts to improve outcomes for underserved patients suffering from critical cardiopulmonary conditions and help save more lives.